Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors

Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors

Gastrointestinal stromal tumors (GISTs) are the most common malignant mesenchymal neoplasms of the gastrointestinal tract. The gold standard for the diagnosis of GISTs is morphologic analysis with an immunohistochemical evaluation plus genomic profiling to assess the mutational status of lesions. Th...

Full description

Bibliographic Details
Main Authors:	Maria Teresa Masucci, Maria Letizia Motti, Michele Minopoli, Gioconda Di Carluccio, Maria Vincenza Carriero
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	International Journal of Molecular Sciences
Subjects:	gastrointestinal stromal tumors drug resistance targeted therapies biomarkers
Online Access:	https://www.mdpi.com/1422-0067/24/7/6026

Similar Items

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer
by: Maria Teresa Masucci, et al.
Published: (2022-01-01)

Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors
by: Xiangchen Hu, et al.
Published: (2022-09-01)

Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
by: Chaoyong Shen, et al.
Published: (2014-11-01)

Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
by: Wen-Kuan Huang, et al.
Published: (2020-05-01)

Surgical intervention of a giant gastric gastrointestinal stromal tumor following neoadjuvant therapy with imatinib
by: Chien-Yang Wang, et al.
Published: (2018-01-01)

Üst gastrointestinal sistem kanaması ile başvuran gastrik gastrointestinal stromal tümör olgusu
by: Doğan Nasır BİNİCİ, et al.
Published: (2017-03-01)

<i>KIT</i> and <i>PDGFRA</i> Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
by: Heikki Joensuu
Published: (2023-07-01)

Type and Gene Location of <i>KIT</i> Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon
by: Lorena Incorvaia, et al.
Published: (2021-02-01)

Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
by: Ryo Katsumata, et al.
Published: (2023-02-01)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
by: Shang-Yu Wang, et al.
Published: (2019-03-01)

Second line of therapy for gastrointestinal stromal tumors: is there a choice?
by: L. M. Kogonia, et al.
Published: (2019-06-01)

Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?
by: Eline L. Giraud, et al.
Published: (2023-05-01)

Gastrointestinal Stromal Tumor Mimicking Ovarian Tumor
by: Özlem Seçilmiş Kerimoğlu, et al.
Published: (2012-12-01)

Unexpected reaction of “wild-type” gastrointestinal stromal tumor to imatinib: case report and literature review
by: Yang He, et al.
Published: (2024-01-01)

A case of primary gastrointestinal stromal tumor of the liver
by: An Nguyen Thi My Xuan, MD, et al.
Published: (2023-12-01)

Gastrointestinal Stromal Tumor of the Stomach with an Abscess Excised by Laparoscopic Surgery
by: Yoshiaki Maeda, et al.
Published: (2016-07-01)

İnce barsak gastrointestinal stromal tümörlerinde acil cerrahi
by: Hacı Hasan Esen, et al.
Published: (2012-01-01)

Gastric volvulus associated with shrinkage of a gastrointestinal stromal tumor by neoadjuvant imatinib: a case report
by: Yoichi Sugiyama, et al.
Published: (2023-01-01)

Karaciğerde Kitle İmajı Veren Gastrointestinal Stromal Tümörün Laparoskopik Rezeksiyonu
by: Ziya Anadol, et al.
Published: (2017-12-01)

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib
by: Ping’an Ding, et al.
Published: (2023-01-01)

Testicular Metastasis of Gastrointestinal Stromal Tumor of the Jejunum
by: Mirsad Dorić, et al.
Published: (2007-05-01)

Secondary resistance to imatinib in gastrointestinal stromal tumors mediated by EPHB2
by: LIU Zong-hang, et al.
Published: (2022-12-01)

Identification and validation of protein biomarkers for predicting gastrointestinal stromal tumor recurrence
by: Juan Sun, et al.
Published: (2024-12-01)

A case of giant unruptured jejunal gastrointestinal stromal tumor
by: Pandiaraja Jayabal, et al.
Published: (2021-01-01)

Extra-Gastrointestinal Stromal Tumor of Prostate
by: Demet Etit, et al.
Published: (2017-04-01)

Rapidly Growing, High-Risk Gastrointestinal Stromal Tumor of the Stomach: A Case Report
by: Sung Jin Lim, et al.
Published: (2023-12-01)

A traumatic means of diagnosing gastrointestinal stromal tumour: A case report
by: M Tun, et al.
Published: (2022-11-01)

Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy
by: Nikolaos Vassos, et al.
Published: (2021-02-01)

Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors
by: Chun Zhuang, et al.
Published: (2023-08-01)

Advanced gastrointestinal stromal tumor: reliable classification of imatinib plasma trough concentration via machine learning
by: Pan Ran, et al.
Published: (2024-02-01)

Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
by: Adnan Asif Parvez Ghias, et al.
Published: (2018-03-01)

A systematic review and network meta-analysis of the efficacy and safety of third-line and over third-line therapy after imatinib and TKI resistance in advanced gastrointestinal stromal tumor
by: Xianhao Xiao, et al.
Published: (2022-11-01)

Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal Tumor
by: Silke Cameron, et al.
Published: (2011-10-01)

Massive gastrointestinal stromal tumor of stomach mimicking a uterine leiomyoma
by: Keyur S Gutte
Published: (2012-01-01)

Changes in imatinib plasma trough level during long-term treatment in patients with intermediate- or high-risk gastrointestinal stromal tumors: Relationship between covariates and imatinib plasma trough level
by: Xingye Wu, et al.
Published: (2023-02-01)

Surgical tactics in the treatment of gastrointestinal stromal tumors of the duodenum
by: A. Yu. Korolkov, et al.
Published: (2019-09-01)

Robotic gastrointestinal stromal tumors surgery - initial results
by: Valentin Ivanov, et al.
Published: (2022-12-01)

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
by: Weihao Li, et al.
Published: (2022-09-01)

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
by: Maria Letizia Motti, et al.
Published: (2020-06-01)

Imatinib and hypophosphatemia: Case report and review of literature
by: Erdem Şen, et al.
Published: (2017-07-01)